Shrieve Chemical Company

Overview

Deal Type Mergers & Acquisitions
Corporate Banking
Client & Transactional Partners Shrieve Chemical Company
Gemspring Capital
Our Role Exclusive Sell-Side Advisor

Summary

On December 2, 2019, KeyBanc Capital Markets (“KBCM”) successfully completed the sale of a majority interest in Shrieve Chemical Company, LLC (“Shrieve”) to Gemspring Capital (“Gemspring”).

KBCM was chosen to serve as exclusive sell-side advisor based on its expertise within the industrial distribution and chemicals sectors, relationship with Shrieve and proven M&A execution capabilities.

Recent Deals

May 2025

christiancare

acquired

crozer

ASCs and Outpatient Centers in Pennsylvania

assets owned by

prospect

Buy-Side Advisor

christianacare-crozer-healths
May 2025

hingehealth

$502.9 Million

Initial Public Offering

Joint Bookrunner

hinge-health
May 2025

sun tribe development

has been acquired by

terraformpower

a portfolio company of

Exclusive Financial Advisor

sun-tribe-development
May 2025

$1.3 Billion

Senior Secured Credit Facilities

Coordinating Lead Arranger
Sole Bookrunner
Administrative Agent
Collateral Agent
Depositary Agent

doral-mammoth-south-central-solar

Connect With Us

Find an Expert